{"product_id":"global-veterinary-molecular-diagnostics-market-size-study-forecast-by-products-instruments-kit-and-reagents-and-software-and-services-application-infectious-diseases-genetics-and-other-applications-technology-pcr-microarray-and-dna-sequenc","title":"Global Veterinary Molecular Diagnostics Market Size study \u0026 Forecast, by Products (Instruments, Kit and Reagents, and Software and Services), Application (Infectious Diseases, Genetics, and Other Applications), Technology (PCR, Microarray, and DNA Sequenc","description":"\u003cp\u003eGlobal Veterinary Molecular Diagnostics Market Size study \u0026amp; Forecast, by Products (Instruments, Kit and Reagents, and Software and Services), Application (Infectious Diseases, Genetics, and Other Applications), Technology (PCR, Microarray, and DNA Sequencing) and Regional Analysis, 2022-2029\u003c\/p\u003e\n\n\u003cp\u003eGlobal Veterinary Molecular Diagnostics Market is valued approximately at USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Veterinary Molecular Diagnostics is the process of identifying the disease in the pet animals by studying the molecules, DNA and RNA. The Veterinary Molecular Diagnostics market is expanding because of factors such as increasing pet animal population and increased animal health expenditure. The market is anticipated to grow in the near future, owing to advancement in veterinary molecular diagnostics and rising demand for Animal-derived Protein based products.\u003c\/p\u003e\n\n\u003cp\u003eAccording to European Pet Food Federation (FEDIAF), in the year 2018, the European population adopting pets was approximately 80 million. Further, Cats, with a constant number of 74.4 million in the EU and 102.7 million in Europe and Russia, are the most popular pets in European families. In 2017, 66.4 million canines were recognized in the EU (84.9 million in Europe and Russia), up from 63.7 million in 2016 (82.2 million). Further, since pet owners are spending more money on a range of pet food items, the market has been growing in line with the rise in pet population. when compared to USD 48.35 billion in 2010. Additionally, it is projected that the pet industry will spend USD 75.38 billion in 2019.. Also, the pet food accounted for around USD 29.07 billion in 2017(44.6 percent of total spending). This in turn, in 2018, rose by 4.3%, bringing total pet food spending to USD 30.32 billion. However, lack of skilled personnel and the high cost of diagnostic tests may restrict the market growth.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Veterinary Molecular Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to rising pet ownership and expenditure. According to the American Pet Products Association's (APPA) 2021–2022 National Pet Owners Assessment, 45.3 million cats and 69 million dogs were there in 90.5 million American households, or roughly 70% of all households. Further, dogs in the country costed approximately USD 242 year for a normal visit, comparable to cats. Since cats costed approximately USD 178. Asia Pacific is expected to grow significantly during the forecast period, owing to rising advancements in the diagnostics.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nNovacyt Group\u003cbr\u003e\nBiochek BV\u003cbr\u003e\nBiomerieux SA\u003cbr\u003e\nBioneer Corporation\u003cbr\u003e\nIdexx Laboratories Inc\u003cbr\u003e\nIngenetix GmbH\u003cbr\u003e\nNeogen Corporation\u003cbr\u003e\nThermo Fischer Scientific Inc\u003cbr\u003e\nVeterinary Molecular Diagnostics Inc\u003cbr\u003e\nBiomedica Group\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\n? Zoetis Inc. bought Basepaws in June 2022. Basepaws is a privately owned pet care genetics company.  This acquisition was made primarily to expand Zoetis' offering in the area of precision animal care. With this acquisition, the company will shape and influence its future pipeline of innovations in pet care.\u003cbr\u003e\n? R-Biopharm AG acquired AusDiagnostics in June 2022. R-Biopharm introduced molecular biology multiplex diagnostics, extraction chemicals, and laboratory automation technology for both animals and humans. Which is done to enhance its product line and the product portfolio in the company.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Veterinary Molecular Diagnostics Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Products, Application, Technology and Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003cbr\u003e\nBy Product:\u003cbr\u003e\nInstruments\u003cbr\u003e\nKit and Reagents\u003cbr\u003e\nSoftware and Services\u003c\/p\u003e\n\n\u003cp\u003eBy Application:\u003cbr\u003e\nInfectious Diseases\u003cbr\u003e\nGenetics\u003cbr\u003e\nOther Applications\u003c\/p\u003e\n\n\u003cp\u003eBy Technology:\u003cbr\u003e\nPCR\u003cbr\u003e\nMicroarray\u003cbr\u003e\nDNA Sequencing\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eNovacyt Group\u003cbr\u003e\nBiochek BV\u003cbr\u003e\nBiomerieux SA\u003cbr\u003e\nBioneer Corporation\u003cbr\u003e\nIdexx Laboratories Inc\u003cbr\u003e\nIngenetix GmbH\u003cbr\u003e\nNeogen Corporation\u003cbr\u003e\nThermo Fischer Scientific Inc\u003cbr\u003e\nVeterinary Molecular Diagnostics Inc\u003cbr\u003e\nBiomedica Group\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"November, 2022 \/ 200 Pages \/ MCW16233820","offer_id":47650829336882,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-veterinary-molecular-diagnostics-market-size-study-forecast-by-products-instruments-kit-and-reagents-and-software-and-services-application-infectious-diseases-genetics-and-other-applications-technology-pcr-microarray-and-dna-sequenc","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}